 |
 |
 |
Aetiology and Genetics of Prostate Cancer
Click on boxes with investigators to view further details
This program is aimed at identifying the genes responsible
for genetic predisposition to prostate cancer (thought to account
for around 15% of cases) and is directed towards (i) identification
and collection of prostate cancer families; (ii) identifying low
and high penetrance genes which predispose to prostate cancer, and
(iii) the development of a program of clinical management for individuals
at high genetic risk of developing cancer. Other groups are focusing
on understanding the role of diet in prostate cancer development
(Professor David Phillips) and the setting up of selenium prevention
trials (Dr Judith Bliss).
|
|
 |
Collaborative
Home Page
Quick Links to other pages
grey = under construction
Aetiology and Genetics
Epidemiological Identification of Families
Genetic Susceptibility
Diet and Environment
Chemoprevention
Molecular Pathology
Links to Cancer Genome Project
Development of Normal Prostate
Microarray Expression Profiling
Candidate Genes
Novel Telomerase Suppressor Genes
Subtractive Hybridization
CESH
Novel Therapies
New Drugs for Prostate Cancer
Intensity Modulated Radiotherapy
Immunotherapy
Novel Targets from Cancer Genome Project
Novel Mechanism Based Drugs
Core Resources
Cancer Gene Cloning Lab
Prostate Tissue arrays
Microarray laboratory
Tissue and blood collections
Bioinformatics
Pilot and Development Funds
Tumor micro-environment in early prostate cancer
Collaborations
Meetings and Seminars
|
 |